CAH targets 13%-15% EPS growth in 2027
CAH issued fiscal 2027 guidance projecting 13%-15% EPS growth, citing performance across segments and continued investment in specialty, pharma, and at-home solutions.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
CAH targets 13%–15% EPS growth in 2027 guidance
CAH issued fiscal 2027 guidance for 13%–15% EPS growth, citing performance across segments and continued investment in specialty, generics, and at-home solutions.